Clinical trials: Induction and Maintaining Remission of Collagenous Colitis
- Condition Induction and Maintaining Remission of Collagenous Colitis
- Funder type Industry (pharma, biotech, devices)
Induction and Maintaining Remission of Collagenous Colitis
SOIBD Collagenous Colitis Maintenance Study
This study aims to demonstrate the superiority of budesonide compared to placebo as maintenance therapy in keeping patients in remission over a one-year period
- Trial name
- SCCMS (NCT01278082)
- Testing
- Budesonide
- Where
- 2 sites in Germany, Sweden
- Volunteers
- 92 people
- Sponsor
- Dr. Falk Pharma GmbH